Brief: Medicinova Receives Notice Of Allowance For New Patent In Brazil
10/01/2023 03:00
Jan 9 (Reuters) - MediciNova Inc MNOV.O :
* MEDICINOVA RECEIVES A NOTICE OF ALLOWANCE FOR A NEW PATENT
COVERING MN-001 AND MN-002 FOR THE TREATMENT OF
HYPERTRIGLYCERIDEMIA, HYPERCHOLESTEROLEMIA, AND
HYPERLIPOPROTEINEMIA IN BRAZIL
Source text for Eikon: ID:nGNX7VZ4m
Further company coverage: MNOV.O
((reuters.briefs@thomsonreuters.com;))
Recent news on Medicinova
See all newsBrief: 3D Investment Partners Cuts Stake In Medicinova To 9.88% From 11.22%, Filing Shows
US STOCKS ON THE MOVE-Mirum Pharmaceuticals, Meta, Boeing
U.S. STOCKS ON THE MOVE-Royal Caribbean Cruises, SpaceX
MediciNova falls as fatty liver drug misses significance on blood-fat reduction
US STOCKS ON THE MOVE-WhiteHawk, Nvidia, Snowflake